← Back to guidelines
Allergy & Immunology53 papers

Episode of harmful use of corticosteroid

Last edited: 4/14/2026

Overview

Harmful use of corticosteroids refers to inappropriate or excessive use leading to adverse outcomes, potentially masking clinical deterioration, especially in palliative care settings 14.

Diagnosis

  • Clinical signs of corticosteroid misuse: rapid weight gain, moon face, buffalo hump, easy bruising 4.
  • Monitoring for masked signs of impending death in palliative care patients receiving dexamethasone 1.
  • Laboratory tests for corticosteroid levels may be considered for confirmation but are not routinely specified 3.
  • Management

  • Tapering and discontinuing corticosteroids under medical supervision to avoid withdrawal symptoms 4.
  • Supportive care addressing specific complications such as infections, metabolic disturbances, and psychiatric issues 4.
  • Communication with patients and families about the risks and benefits of corticosteroid use 4.
  • Special Populations

  • Palliative Care: Caution in recognizing the dying phase due to potential masking effects of dexamethasone on clinical deterioration 1.
  • No specific guidance provided for pregnancy, pediatrics, or elderly populations 234.
  • Key Recommendations

  • Closely monitor palliative care patients on dexamethasone for signs of masked clinical decline, adjusting care plans accordingly (Evidence: Weak 1).
  • Implement a structured tapering regimen when discontinuing corticosteroids to prevent withdrawal symptoms (Evidence: Expert opinion 4).
  • Enhance communication strategies with patients and families regarding the risks of corticosteroid misuse, particularly in palliative settings (Evidence: Expert opinion 4).
  • References

    1 van Esch HJ, Lokker ME, Geijteman EC, van der Heide A, van Zuylen L. Can the Dying Phase Be Masked by the Use of Dexamethasone? A Case Report. Journal of pain & palliative care pharmacotherapy 2016. link 2 Borchers AT, Keen CL, Gershwin ME. Use and misuse of corticosteroids. Comprehensive therapy 2003. link 3 Creaser CS, Feely SJ, Houghton E, Seymour M. Immunoaffinity chromatography combined on-line with high-performance liquid chromatography-mass spectrometry for the determination of corticosteroids. Journal of chromatography. A 1998. link00888-1) 4 Goldberg RL, Wise TN. Corticosteroid abuse revisited. International journal of psychiatry in medicine 1986. link

    Original source

    1. [1]
      Can the Dying Phase Be Masked by the Use of Dexamethasone? A Case Report.van Esch HJ, Lokker ME, Geijteman EC, van der Heide A, van Zuylen L Journal of pain & palliative care pharmacotherapy (2016)
    2. [2]
      Use and misuse of corticosteroids.Borchers AT, Keen CL, Gershwin ME Comprehensive therapy (2003)
    3. [3]
    4. [4]
      Corticosteroid abuse revisited.Goldberg RL, Wise TN International journal of psychiatry in medicine (1986)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG